PolyPid Competitors and Similar CompaniesClear all
Metabolon's competitors and similar companies include Adaptimmune, VBI Vaccines and Meissa Vaccines.
 Metabolon Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research. |  Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. |  VBI Vaccines VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. |  Meissa Vaccines Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus. | |
Founding Date | Founding Date 2000 | Founding Date 2008 | Founding Date 2001 | Founding Date 2014 |
Type | Type Private | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Morrisville, US HQ Hallbergmoos, DE München, DE | Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB | Locations Cambridge, US HQ Ottawa, CA Rehovot, IL | Locations South San Francisco, US HQ Redwood City, US |
Employees | Employees 1911% increase | Employees 4007% decrease | Employees 12314% increase | Employees 3 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 188.5 m | Valuation ($) 1.9 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $178m (FY, 2024) | Revenue (est.) $8.7m (FY, 2023) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($70.8m) (FY, 2024) | Net income ($92.8m) (FY, 2023) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round $ 15m (over 9 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 30m (almost 7 years ago) |
Total funding raised | Total funding raised $ 95.4m | Total funding raised $ 107.5m | Total funding raised N/A | Total funding raised $ 33.4m |
For sources of this data, please see the company profile
View Company Profiles
Adaptimmune
HQ
Philadelphia, US
Employees
400↓ 7% decrease
Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
View companyVBI Vaccines
HQ
Cambridge, US
Employees
123↑ 14% increase
VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.
View companyMeissa Vaccines
HQ
South San Francisco, US
Employees
3
Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus.
View company